Evaluation of ravulizumab trough levels in pediatric complement-mediated hemolytic uremic syndrome in remission.

Nunez SMM, Brokenshire S, Srivaths P, Angelo J, Shah S, Michael M

Open source

DOI
10.1007/s00467-025-07113-5
Published
2026 Jun
Container
Pediatric nephrology (Berlin, Germany)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00467-025-07113-5,
  title = {Evaluation of ravulizumab trough levels in pediatric complement-mediated hemolytic uremic syndrome in remission.},
  author = {Nunez SMM and Brokenshire S and Srivaths P and Angelo J and Shah S and Michael M},
  year = {2026},
  journal = {Pediatric nephrology (Berlin, Germany)},
  doi = {10.1007/s00467-025-07113-5},
  url = {https://doi.org/10.1007/s00467-025-07113-5}
}

RIS

TY  - JOUR
TI  - Evaluation of ravulizumab trough levels in pediatric complement-mediated hemolytic uremic syndrome in remission.
AU  - Nunez SMM
AU  - Brokenshire S
AU  - Srivaths P
AU  - Angelo J
AU  - Shah S
AU  - Michael M
PY  - 2026
JO  - Pediatric nephrology (Berlin, Germany)
DO  - 10.1007/s00467-025-07113-5
UR  - https://doi.org/10.1007/s00467-025-07113-5
ER  - 

APA

SMM, N., S, B., P, S., J, A., S, S., & M, M. (2026). Evaluation of ravulizumab trough levels in pediatric complement-mediated hemolytic uremic syndrome in remission.. Pediatric nephrology (Berlin, Germany). https://doi.org/10.1007/s00467-025-07113-5

Source records